| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.0008 | 1 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00096 | 1 |